Gum regrowth showdown: microneedling with PRF vs hyaluronic acid
NCT ID NCT07280507
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small early trial tests whether microneedling combined with a patient's own platelet-rich fibrin (i-PRF) can rebuild lost gum tissue between teeth better than hyaluronic acid gel injections. Seven adults with mild gum recession are being studied. The goal is to find a less invasive alternative to surgery for improving gum appearance.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Injectable Platelet Rich Fibrin (i-PRF) and Hyaluronic Acid gel
- What this could lead to
- If it works, this could offer a minimally invasive, biologically active alternative to surgery for restoring gum tissue between teeth.
- What could go wrong
- This is a very early, tiny trial (only 7 people) testing a cosmetic dental procedure. Results may not apply to everyone, and the approach may not prove better than existing options.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Early phase 1
The earliest testing in people: a first look at safety, in a very small group.
- Participants
-
About 7 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2025
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Plaque index \<1 * Gingival index \<1 * Class I papillary loss (Nordland and Tarnow classification) * Probing depth ≤4 mm at the test site * Inter-proximal bone crest distance ≤7 mm from the contact point. Exclusion Criteria: * Pregnancy * Lactation * Uncontrolled systemic diseases (e.g., diabetes) * Anticoagulant therapy * Recent radiotherapy * Orthodontic treatment * Midline diastema * High frenum attachment * Class II/III papillary loss.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Papilla reconstruction are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
King AbdulAziz University
Jeddah, Saudi Arabia
More trials for these conditions
Other studies related to the condition(s) this trial covers.